Fund Mojo help you discover the best fund managers, funds, and related information

Fund Intelligence | Best Managers | SHSAX Insights | SHSAX Score | SHSAX Performance | SHSAX News | SHSAX Allocation | SHSAX Holdings Change

BlackRock Health Sciences Opps Inv A (SHSAX) Fund Ranking and Research

Ranking, Research and Recommendation of BlackRock Health Sciences Opps Inv A (SHSAX) Fund

    Last Trade: $ on , Change: (0%)

 

Graph of BlackRock Health Sciences Opps Inv A Fund (SHSAX) ManagerFund Manager - Thomas Callan

Fund Manager Information

Fund Manager Tenure: 15.5 years
Similar Funds: SHSCX  SHSPX  SHSSX 
Fund Family: BlackRock
Fund Category: Health
Fund Performance: May 30, 2016
Fundmojo Fund Grade: A+ (Score: 0.8)     (What does this score mean?)

 

Graph of BlackRock Health Sciences Opps Inv A Fund (SHSAX) ProfileBlackRock Health Sciences Opps Inv A Fund (SHSAX) Profile

Fund Profile and Description

BlackRock Health Sciences Opps Inv A Fund seeks to provide long-term growth of capital. BlackRock Health Sciences Opps Inv A Fund typically invests at least 80% of assets in securities of companies in health science and related industries. Such securities may include common and preferred stock, convertible securities, warrants, depositary receipts and certain derivative securities. It invests more than 25% of assets in health sciences or related industries, and may invest in companies located in non-U.S. countries. BlackRock Health Sciences Opps Inv A Fund also may invest up to 20% of total assets in other securities. It may invest without limit in shares of companies through initial public offerings (IPOs). BlackRock Health Sciences Opps Inv A Fund is non-diversified.

 

BlackRock Health Sciences Opps Inv A (SHSAX) Fund Strength What we like about BlackRock Health Sciences Opps Inv A (SHSAX) Fund

Data for BlackRock Health Sciences Opps Inv A Fund (SHSAX) as of May 30, 2016

  • BlackRock Health Sciences Opps Inv A Fund (SHSAX) management has been with BlackRock Health Sciences Opps Inv A Fund for 15.5 years
  • BlackRock Health Sciences Opps Inv A Fund (SHSAX) has good short-term performance (1-year return -6.82% vs -12.93% Health category median performance)
  • BlackRock Health Sciences Opps Inv A Fund (SHSAX) has good mid-term performance (3-year return 17.88% vs 15.21% Health category median performance)
  • BlackRock Health Sciences Opps Inv A Fund (SHSAX) has good Long-term performance (5-year return 17.01% vs 16.08% Health category median performance)
  • BlackRock Health Sciences Opps Inv A Fund (SHSAX) ratio of up-years vs down years is greater than 2
  • BlackRock Health Sciences Opps Inv A Fund (SHSAX) has a Morningstar rating of 4 and above
  • Asset base in BlackRock Health Sciences Opps Inv A Fund (SHSAX) has been consistently increasing at a reasonable pace in the last 2 months. It shows investor confidence and market support
  • BlackRock Health Sciences Opps Inv A Fund (SHSAX) is less volatile than its peers as it has a 3-year Standard Deviation of 14.9, lower than category average of 17.59
  • BlackRock Health Sciences Opps Inv A Fund (SHSAX) has a lower expense ratio than its Health average: 1.15% vs 1.32%

BlackRock Health Sciences Opps Inv A Fund (SHSAX) Weakness What we are cautious about BlackRock Health Sciences Opps Inv A (SHSAX) Fund

Data for BlackRock Health Sciences Opps Inv A Fund (SHSAX) as of May 30, 2016

  • BlackRock Health Sciences Opps Inv A Fund (SHSAX) has an annual stock turnover rate of 50.00% that is higher than the Health average of 43.99%. This could mean BlackRock Health Sciences Opps Inv A is more nimble, but also signal potential high tax impact and high trading fees
  • BlackRock Health Sciences Opps Inv A Fund (SHSAX) carries a 5.25% load
  • As a Health focused fund, BlackRock Health Sciences Opps Inv A Fund (SHSAX) is less diversified and has inherited sector risks associated with the fund
See BlackRock Health Sciences Opps Inv A Fund (SHSAX) performance details as of May 30, 2016

 

What do you think?

 

Compare BlackRock Health Sciences Opps Inv A Fund (SHSAX)Compare with other top Health category mutual funds

Aadditional top Health mutual funds for your consideration

FundYear to Date1 Year3 year5 year
BlackRock Health Sciences Opps Inv A-3.40-6.8217.8817.01
Fidelity Advisor Health Care A (FACDX)-5.84-13.4918.7717.80Compare
Hartford Healthcare A (HGHAX)-6.82-7.8017.3816.39Compare
Janus Global Life Sciences T (JAGLX)-7.78-15.8319.3919.37Compare

See top fund managers for Health Category Funds

 

Compare BlackRock Health Sciences Opps Inv A Fund (SHSAX)Compare with Health category ETFs

Some Health ETFs for your consideration

ETFYear to DateOne YearThree Year
First Trust NYSE Arca Biotech ETF (FBT)000
SPDR S&P Health Care Equipment ETF (XHE)000
SPDR S&P Biotech ETF (XBI)000
PowerShares S&P SmallCap Health Care ETF (PSCH)000
PowerShares Dynamic Pharmaceuticals ETF (PJP)000

 

Graph of BlackRock Health Sciences Opps Inv A Fund (SHSAX) Net Asset TrackingBlackRock Health Sciences Opps Inv A (SHSAX) Fund Net Asset

Track net asset change of BlackRock Health Sciences Opps Inv A fund (SHSAX)

DateNet Asset
05/2016$5.65B
03/2016$5.38B
02/2016$5.28B
More historic net asset information on BlackRock Health Sciences Opps Inv A Fund (SHSAX)

  

Graph of BlackRock Health Sciences Opps Inv A Fund (SHSAX) Portfolio TrackingBlackRock Health Sciences Opps Inv A (SHSAX) Fund Portfolio Allocation

Track portfolio allocation change of BlackRock Health Sciences Opps Inv A fund (SHSAX)

DateCashStockBondOther
04/20164.25%94.45%0%1.3%
02/20163.82%94.72%0%1.46%
01/20164.86%92.89%0%2.25%
Click here to see more historic asset allocation information on BlackRock Health Sciences Opps Inv A Fund (SHSAX)

 

graph of BlackRock Health Sciences Opps Inv A Fund (SHSAX) Top 10 Position TrackingTop 10 Holdings in BlackRock Health Sciences Opps Inv A (SHSAX) Fund

Discover what BlackRock Health Sciences Opps Inv A Fund (SHSAX) manager is buying

Apr 29, 2016
UnitedHealth Group Incorporated [5.59%]
Medtronic plc. Ordinary Shares [4.59%]
Boston Scientific Corporation C [4.3%]
Celgene Corporation [4.12%]
Amgen Inc. [3.36%]
Eli Lilly and Company Common St [3.31%]
Bristol-Myers Squibb Company Co [3.04%]
Merck & Company, Inc. Common St [2.61%]
Allergan plc Ordinary Shares [2.34%]
Johnson & Johnson Common Stock [2.15%]

Feb 28, 2016
UnitedHealth Group Incorporated [5.68%]
Medtronic plc. Ordinary Shares [4.85%]
Celgene Corporation [4.13%]
Boston Scientific Corporation C [3.76%]
Allergan plc Ordinary Shares [3.53%]
Amgen Inc. [3.28%]
Eli Lilly and Company Common St [3.25%]
Bristol-Myers Squibb Company Co [3.03%]
Merck & Company, Inc. Common St [2.22%]
Johnson & Johnson Common Stock [2.15%]

Jan 30, 2016
UnitedHealth Group Incorporated [4.96%]
Medtronic plc. Ordinary Shares [4.77%]
Eli Lilly and Company Common St [4.04%]
Celgene Corporation [4.04%]
Amgen Inc. [3.76%]
Allergan plc Ordinary Shares [3.51%]
Boston Scientific Corporation C [3.42%]
Bristol-Myers Squibb Company Co [3.14%]
Gilead Sciences, Inc. [2.29%]
Teva Pharmaceutical Industries [2.07%]
Click here for Stock Holding Change Map in BlackRock Health Sciences Opps Inv A Fund (SHSAX)

  

Latest News on BlackRock Health Sciences Opps Inv A (SHSAX) Fund

See what is happening with BlackRock Health Sciences Opps Inv A Fund (SHSAX)

    No recent news

 

BlackRock Health Sciences Opps Inv A Fund (SHSAX) Related ResourcesSee more information on BlackRock Health Sciences Opps Inv A (SHSAX) Fund

Popular pages on BlackRock Health Sciences Opps Inv A (SHSAX) Fund

  

Fund Mojo Newsletter

Fund Mojo on Facebook Follow FundMojo on Twitter Fund Update